Why the study?
Practice guidelines were needed to provide evidence-based recommendations on the management of neuromuscular monitoring and antagonism of neuromuscular blocking agents during and after general anesthesia to reduce residual neuromuscular blockade.
These guidelines establish evidence-based recommendations for the monitoring and antagonism of neuromuscular blockade to prevent residual blockade in patients undergoing general anesthesia.
Answers are grounded in this paper and cite their sources.
Clinicians should adopt recommended monitoring sites and antagonism processes to minimize residual blockade; extends evidence-based standards for safe general anesthesia.
These practice guidelines provide evidence-based recommendations on the management of neuromuscular monitoring and antagonism of neuromuscular blocking agents during and after general anesthesia. The guidance focuses primarily on the type and site of monitoring and the process of antagonizing neuromuscular blockade to reduce residual neuromuscular blockade.
No takes yet. Share an insight, caveat, or question.
Thilen et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: